SCHEMBL21369901

SCHEMBL21369901

c1ccc(-c2ccc(-c3cc(-c4ccccc4)cc(-c4cc(-c5cc6ccccc6c6ccccc56)cc(-n5c6ccccc6c6ccccc65)c4)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.39
KDM4E B2RXH2 4/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HTR6 P50406 2/20 0.35
ACACA Q13085 1/20 0.35
CYP19A1 P11511 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
DHODH Q02127 1/20 0.34
ALOX5 P09917 2/20 0.34
MCL1 Q07820 1/20 0.33
MPI P34949 1/20 0.33
MYC P01106 1/20 0.32
GPR84 Q9NQS5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21369900 0.99 CYP11B1 (0.40) CYP11B1KDM4EL3MBTL1ATMALDH1A1
SCHEMBL21369896 0.97 CYP11B1 (0.40) CYP11B1KDM4EL3MBTL1ATMALDH1A1
SCHEMBL21370261 0.95 CYP11B1 (0.36) CYP11B1KDM4EL3MBTL1ATMALDH1A1
SCHEMBL21370263 0.95 CYP11B1 (0.36) CYP11B1KDM4EL3MBTL1ATMALDH1A1
SCHEMBL21369897 0.95 CYP11B1 (0.39) CYP11B1KDM4EL3MBTL1ATMALDH1A1
SCHEMBL21370215 0.94 CYP11B1 (0.36) CYP11B1KDM4EL3MBTL1ATMALDH1A1
SCHEMBL21369962 0.94 CYP11B1 (0.38) CYP11B1KDM4EL3MBTL1ATMALDH1A1
SCHEMBL21369895 0.93 TUBB4A (0.39) CYP11B1KDM4EL3MBTL1ATMALDH1A1
SCHEMBL21370379 0.92 CYP11B1 (0.35) CYP11B1KDM4EL3MBTL1ATMALDH1A1
SCHEMBL21370258 0.92 L3MBTL1 (0.39) CYP11B1KDM4EL3MBTL1ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SOULBRAIN CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 CYP11B1 37/4885KDM4E 2473/4885L3MBTL1 1787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.